P33 Thirty-six-month amyloid PET results show continued reduction in amyloid burden with gantenerumab

التفاصيل البيبلوغرافية
العنوان: P33 Thirty-six-month amyloid PET results show continued reduction in amyloid burden with gantenerumab
المؤلفون: A. Davis, Geoffrey A. Kerchner, Paul Delmar, Nicola Voyle, Paulo Fontoura, Danielle Abi-Saab, Carsten Hofmann, Rachelle Doody, T. Duning, Gregory Klein, Smiljana Ristic, Monika Baudler
المصدر: Clinical Neurophysiology. 131:e195
بيانات النشر: Elsevier BV, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Amyloid pet, Sensory Systems, Neurology, Physiology (medical), Internal medicine, Medicine, Amyloid burden, Neurology (clinical), business, Gantenerumab, medicine.drug
تدمد: 1388-2457
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5b605b58117f0be014dbd668851a19a1Test
https://doi.org/10.1016/j.clinph.2019.12.039Test
حقوق: CLOSED
رقم الانضمام: edsair.doi...........5b605b58117f0be014dbd668851a19a1
قاعدة البيانات: OpenAIRE